Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining around 150 points on Monday.

Shares of Abbott Laboratories (NYSE:ABT) fell in today’s pre-market trading after the company was ordered to pay $495 million in damages in its baby formula case.

Abbott shares lost 6.6% to $98.29 in pre-market trading

Integra LifeSciences Holdings Corporation (NASDAQ:IART) dipped 20.5% to $25.00 in pre-market trading after the company reported second-quarter results and lowered its FY24 outlook.
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) fell 13.8% to $16.26 in pre-market trading as the company announced topline data from pivotal Phase 3 BROOKLYN clinical trial evaluating Obicetrapib in patients wth Heterozygous Familial Hypercholesterolemia.
EZCORP, Inc. (NASDAQ:EZPW) shares declined 8.8% to $9.41 in pre-market trading.
GeoPark Limited (NYSE:GPRK) shares fell 6.5% to $9.52 in pre-market trading. GeoPark, last week, issued second quarter operational update.
Immutep Limited (NASDAQ:IMMP) shares dipped 6.5% to $2.03 in pre-market trading. Immutep, last week, announced successful meeting with the FDA on Phase III design in non-small cell lung cancer.
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) shares fell 5.4% to $8.75 in pre-market trading.
ICL Group Ltd (NYSE:ICL) shares fell 4.1% to $4.43 in pre-market trading. ICL will release second quarter results before the opening of the TASE market on Wednesday, Aug. 14.
PDD Holdings Inc. (NASDAQ:PDD) slipped 3% to $126.84 in pre-market trading.